Generic prescribing increased sharply in the US last year as a number of major pharma brands went off-patent.
The Generic Drug Savings In The US study, conducted for the Pharmaceutical Association (GPhA) by IMS Health, found generics now account for nearly 80 per cent of US prescriptions.
2011 saw the largest year-on-year increase in US generic prescribing since 1998, according to the study, which also found generics saved US consumers, taxpayers, federal and state governments and other payers $1.07tn between 2002 and 2011. (Más)
No hay comentarios:
Publicar un comentario